Channing Der has been named a Fellow of the American Association for the Advancement of Science (AAAS) for “distinguished contributions to the field of cancer research through the discovery of RAS in cancer and the elucidation of RAS oncoprotein function and therapies.”

Der, who joined the UNC School of Medicine in 1992 as an associate professor, received his doctorate from the University of California, Irvine, and he then completed his postdoctoral studies at Harvard Medical School/Dana-Farber Cancer Institute. His research has centered on the study of the RAS oncogene and cancer and has been funded by grants from the National Cancer Institute (NCI), Lustgarten Foundation, and the Pancreatic Cancer Action Network.

Recently, his lab discovered an approach to make pancreatic cancer cells reliant on one energy source and then starve them of it, a finding that has led to clinical studies of a new treatment strategy for one of the most deadly forms of cancer.

Read the full article here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s